Versuchen GOLD - Frei

BioSpectrum Asia - December 2024

Mit Magzter GOLD unbegrenztes Potenzial nutzen

Lesen BioSpectrum Asia zusammen mit über 9.000 anderen Zeitschriften und Zeitungen mit nur einem Abonnement

Katalog anzeigen

1 Monat

$14.99

1 Jahr $149.99

$149.99

$12/month

(OR)

Abonnieren Sie nur BioSpectrum Asia

Geschenk BioSpectrum Asia

Jederzeit kündbar.

(Keine Verpflichtungen) ⓘ

Sollten Sie mit Ihrem Abonnement nicht zufrieden sein, senden Sie uns innerhalb von 7 Tagen nach Abonnementbeginn eine E-Mail an help@magzter.com, um eine vollständige Rückerstattung zu erhalten. Versprochen! (Hinweis: Gilt nicht für den Kauf einzelner Ausgaben.)

Digitales Abonnement

Sofortiger Zugriff ⓘ

Abonnieren Sie jetzt, um sofort mit dem Lesen auf der Magzter-Website sowie in den iOS-, Android- und Amazon-Apps zu beginnen.

Verifiziert sicher

zahlen ⓘ

Magzter ist ein verifizierter Authorize.Net-Händler. Weitere Informationen

In dieser Ausgabe

2025 Trends
Buoying Boom
Phase in APAC
Like many industries, life sciences, too, faced numerous challenges in 2024, such as a
slowing economy, and geopolitical conflicts. Despite these headwinds, the sector has
shown remarkable resilience, with strong prospects for recovery and growth. Significant
investments are being directed toward research and development in key areas such as
Antibody Drug Conjugates (ADCs), Cell and Gene Therapies, Artificial Intelligence (AI) and
Contract Development and Manufacturing Organisations (CDMOs) and many more. These
f
ields have been major drivers of growth this year and offer promising opportunities. It’s
that time of year again when we interact with leaders from major market segments of the
industry. These leaders provide their insights into what the coming year is likely to hold for
their respective fields. Lets look into a few trends from life sciences that are expected to
make a significant splash in 2025

BioPharma's Transformative & Strategic OUTLOOK 2025

The Indian biopharma industry witnessed notable transformative developments and announcements, marked by innovation, regulatory advancements, and market expansion this year. From achieving global recognition in biosimilars to advancing biomanufacturing capabilities and precision therapeutics, the sector has solidified its role as a key player in the global pharmaceutical landscape. This progress underscores India's strategic focus on leveraging its robust infrastructure, skilled talent pool, and government support to meet the evolving demands of the healthcare industry.

10+ mins

Indian Lifesciences Industry Going Ahead in its Innovation Journey While Navigating Challenges

While India is a hub for biosimilar manufacturing and continues to build its capabilities to manufacture these complex therapeutics, Indian biopharma companies are building R&D capabilities and establishing public-private collaborations and Centre of Excellences (CoEs) to develop innovative biologics and advanced therapeutic modalities like cell and gene therapy (CGT) and mRNA vaccines and therapies, biopharma sector remained robust in 2023, accounting for $53.8 billion (35 per cent of the BioEconomy). The growth was primarily driven by advances in biotechnology, personalised medicine innovations, and an expanding market for biosimilars in 2024.

5 mins

What's dampening the GLOBAL AMR BATTLE?

Although there have been significant national and worldwide efforts to provide financial incentives for antibiotic research and development, it is still unclear how best to fortify the existing programmes to further spur antibiotic innovation. The incentive programmes in place now are a crucial first step in enhancing the economic viability of antibiotic development. However, it seems like there isn't enough global coordination among all the programmes, which could lead to duplication of effort, funding gaps in the value chain, and the failure to include crucial AMR objectives. Let's dig deeper.

9 mins

How To Control Indian Diabetes Growth

World Diabetes Day, observed on November 14, reminds us of the growing impact of diabetes on global health and the urgent need for collective action to prevent, diagnose, and manage this chronic condition. In 2024, the theme 'Breaking Barriers, Bridging Gaps' underscores the critical importance of accessible, high-quality diabetes care, especially for underrepresented communities. The Government of India has taken many measures intending to reduce the prevalence of diabetes and alleviate its long-term complications, contributing to a healthier future for all citizens.

4 mins

How strategic angel investment is driving global expansion in medtech and diagnostics

India has firmly established itself as a key player in the global medtech and diagnostics sectors. With a burgeoning healthcare ecosystem and a growing focus on innovation, the country offers a fertile ground for startups looking to scale their solutions both domestically and internationally. Central to this growth is the role of strategic angel investment, which not only provides financial backing but also offers critical mentorship and strategic direction to help these companies expand their reach.

4 mins

Innovations in Urological Imaging: Transforming Patient Care in India

Despite advancements in urological imaging, challenges persist in India, particularly regarding cost and accessibility. Government initiatives and public-private partnerships should expand access to imaging facilities. Continued research investment is crucial for developing cost-effective solutions.

5 mins

Karnataka launches India's first GCC policy

Bengaluru Tech Summit 2024

8 mins

HIV Prevention Remains Elusive

On December 1, the world gathers every year to commemorate World AIDS Day, which serves as an important reminder that we must remain steadfast in our commitment to prevent new HIV (Human Immunodeficiency Virus) infections and provide essential services to all people living with HIV globally. In 2024, the 37th World AIDS Day opens with the theme, \"Collective Action: Sustain and Accelerate HIV Progress.\"

2 mins

Lesen Sie alle Geschichten von BioSpectrum Asia

BioSpectrum Asia Description:

Herausgeber: MM-Activ-Sci-Tech-Communication

Kategorie: Business

Sprache: English

Frequenz: Monthly

BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:

* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.

* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.

* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.

* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.

* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.

BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.